Bloom Science a biopharmaceutical company developing microbiomederived therapeutics in multiple neurological conditions and oncology today announced the launch of a research agreement with CedarsSinai Medical Center The collaboration will focus on advancing the understanding of the microbiome in a P...

Engitix Ltd Engitix a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix ECM platform and Morphic Therapeutic Morphic a biopharmaceutical company developing oral integrin therapies today announce that they have en...

Samyang Biopharm USA Inc a global biotech subsidiary of the Samyang Pharmaceuticals Corp announced today that the company has entered into a research collaboration with the exclusive option to a worldwide licensing agreement with Talix Therapeutics NV Financial terms of the agreement were not disclo...

Avitide Inc the industry leader in the discovery and development of custom affinity purification resins announces that it has entered into an exclusive license agreement to support the development of one of Gemini Therapeutics therapeutic programs

Janssen Biotech Inc a Janssen Pharmaceutical Company of Johnson Johnson announced today that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc Bermekimab is an antiILalpha monoclonal antibody mAb in Phase development for the tr...

GE Healthcare Life Sciences and Advanced Solutions Life Sciences ASLS will enter into a strategic RD and distribution partnership that sets out to personalize tissue regeneration The integration of IN Cell Analyzer and BioAssemblyBot systems technologies will embed cellularlevel assessments into the...

MaxCyte the global cellbased therapies and life sciences company and KSQ Therapeutics a biotechnology company using its proprietary CRISPRomics discovery platform to achieve higher probabilities of success in drug development announced today that the companies have entered into a new development and...

Zionexa a radiopharmaceutical company specialized in the development and commercialization of invivo biomarkers for use in guiding targeted therapies in oncology and PETNET Solutions Inc a Siemens Healthineers company specializing in the manufacturing and distribution of positron emission tomography...

Gatehouse Bio a pioneer in nextgeneration therapeutics is collaborating with AstraZeneca a global scienceled biopharmaceutical company to explore the identification of new targets for respiratory and cardiovascular diseases using Gatehouse Bios Artificial Intelligence AIpowered platform

Zealand Pharma AS a Copenhagenbased biotechnology company focused on the discovery and development of innovative peptidebased medicines announces that partner Beta Bionics Inc has received Breakthrough Device designation from the US Food and Drug Administration FDA for its iLet Bionic Pancreas Syst...

Dermira Inc a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated new therapies to the millions of patients living with chronic skin conditions today announced that the US Food and Drug Administration FDA has granted Fast Track design...

According to studies an evergreater number of staff members are complaining about increasing mental stress Nevertheless according to a recent survey among staff members commissioned by LinkedIn percent of employers do not offer any preventive actions for stress symptoms such as tension or sleep dis...

MetP Pharma AG today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office USPTO for its patent entitled Treatment of Demyelinating Diseases US Appl No Valid until the patent addresses a method to treat demyelinating diseases such as multiple scler...

QuVa Pharma Inc today announced it has signed a production and distribution agreement with Hibernation Therapeutics for its patented cardioplegia solution Adenocaine the combination of Adenosine Lidocaine and Magnesium Sulfate that is used to intentionally stop the heart from beating during cardiac...

Sangamo Therapeutics Inc a genomic medicine company and Pfizer Inc NYSE PFE today announced updated followup results from the Phase Alta study evaluating investigational SB gene therapy in patients with severe hemophilia A The data showed that SB was generally well tolerated and demonstrated sustai...

The M expansion has tripled the facilitys footprint to approximately sq ft significantly expanding capacity and supporting MedPharms continued commitment to the topical and transdermal market

Galectin Therapeutics Inc the leading developer of therapeutics that target galectin proteins recently presented its current plans for an Adaptively Designed Phase clinical trial NASHRX of its lead compound belapectin GRMD in the treatment of patients with nonalcoholic steatohepatitis NASH cirrhosi...

Alector Inc a clinical stage biotechnology company pioneering immunoneurology today announced that the US Food and Drug Administration FDA has granted Fast Track designation for its investigational therapeutic AL for the treatment of patients with frontotemporal dementia FTD carrying specific geneti...